Harnessing Advanced Biologics to Enhance Bone Regeneration and Implant Success
-
By
-
George A. Mandelaris
-
September 1, 2026
-
3 min
Clinical Report: Harnessing Advanced Biologics to Enhance Bone Regeneration
Background
The integration of advanced biologics in implant dentistry is crucial for improving patient outcomes in bone regeneration. The evolution of biologics and growth factor technologies has expanded treatment options for patients requiring bone reconstruction.
Data Highlights
No numerical data provided in the source material.
Key Findings
- INDUCE Oi-9® enhances regeneration outcomes, appearing similar to native bone upon re-entry.
- The proprietary NMP® processing protocol increases the bioavailability of multiple native growth factors.
- INDUCE Oi-9® is associated with improved bone quality and quantity while minimizing postoperative edema.
- The material is versatile and easy to use across various regenerative procedures.
- It has a 5-year shelf-life and can be stored at room temperature, streamlining inventory management.
Clinical Implications
Clinicians may consider incorporating INDUCE Oi-9® into their regenerative protocols to enhance bone regeneration outcomes. The material's favorable handling characteristics and storage convenience may also facilitate its use in diverse clinical settings.
Conclusion
The advancements in biologics, particularly INDUCE Oi-9®, represent significant progress in the field of regenerative dentistry, contributing to more predictable treatment outcomes.
Related Resources & Content
- George A. Mandelaris, DDS, MS, Induce Biologics, 2023 -- Harnessing Advanced Biologics to Enhance Bone Regeneration and Implant Success
- Compendium, 2026 -- Regenerative Materials in Site Preparation for Implant Placement: A Clinically Validated Histological Perspective
- Compendium, 2026 -- Bioactive Bone Grafting Designed to Support Predictable Regeneration
- Compendium, 2025 -- Beyond Osseointegration: Biomaterials for Oral Regeneration in Implant Dentistry
- Frontiers in Immunology, 2026 -- Biomaterial physicochemical properties govern immune activation and bone regeneration
- Clinical Oral Implants Research, 2026 -- Proceedings of the 1st Global Consensus for Clinical Guidelines
- PubMed, 2026 -- BMP-2 in oral-maxillofacial bone augmentation: a systematic review and meta-analysis
- PMC, 2026 -- Comparative Efficacy of Platelet-Rich Fibrin, Freeze-Dried Bone Allograft, or Spontaneous Healing for Alveolar Ridge Preservation
- Special Issue: Proceedings of the 1st Global Consensus for Clinical Guidelines: Clinical Oral Implants Research: Vol 37, No S30
- BMP-2 in oral-maxillofacial bone augmentation: a systematic review and meta-analysis - PubMed
- Comparative Efficacy of Platelet-Rich Fibrin, Freeze-Dried Bone Allograft, or Spontaneous Healing for Alveolar Ridge Preservation: Systematic Review and Meta-Analysis - PMC
Based on findings from:
Harnessing Advanced Biologics to Enhance Bone Regeneration and Implant Success
George A. Mandelaris. Compendium, 2026.
https://compendiumlive.com/2026/09/harnessing/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
